The Growing Threat of Synthetic Drugs: INCB Calls for Urgent Action
The Growing Threat of Synthetic Drugs: INCB Calls for Urgent Action
The International Narcotics Control Board (INCB) has raised the alarm over the rapid expansion of the illicit synthetic drug industry, warning that its impact on global public health could be catastrophic. Unlike plant-based drugs, synthetic substances can be manufactured anywhere, without the need for large-scale cultivation. This makes them cheaper and easier for traffickers to produce and distribute, fueling an escalating crisis.
In its 2024 Annual Report, released on Tuesday, the INCB highlights how highly potent opioids like FYL and nitazenes—capable of causing overdoses in minuscule doses—have driven drug-related deaths to record highs.
“The rapid expansion of the illicit synthetic drug industry represents a major global public health threat with potentially disastrous consequences for humankind,” said INCB President Jallal Toufiq.
“We need to work together to take stronger action against this deadly problem, which is causing hundreds of deaths and untold harm to communities.”
Traffickers Stay Ahead of Regulations
Criminal organizations are constantly adapting, finding new ways to bypass regulations and evade law enforcement.
By exploiting legal loopholes, traffickers synthesize new drug compounds and even use artificial intelligence to identify alternative chemicals for production. Meanwhile, they are developing innovative smuggling methods, including the use of drones and postal deliveries, making these drugs harder to detect and intercept.
As a result, seizures of synthetic substances have surpassed those of traditional plant-based drugs like heroin and cocaine, underscoring the growing dominance of the synthetic drug market.
A Fragmented Response Leaves Gaps for Traffickers
Despite global efforts to combat synthetic drug trafficking, responses remain inconsistent, allowing criminal networks to stay ahead.
The INCB is calling for stronger international cooperation, urging governments, private companies, and international organizations to work together to disrupt supply chains and reduce harm. Without a coordinated strategy, traffickers will continue to exploit weak links in enforcement efforts.
Millions Still Lack Access to Essential Medication
While synthetic drugs flood illegal markets, millions of people in low- and middle-income countries still struggle to access pain relief medication.
The report highlights that opioid painkillers like morphine remain out of reach in regions such as Africa, South Asia, and Central America. This is not due to supply shortages but rather barriers in distribution and strict regulations.
The INCB is urging opioid-producing nations to ramp up production and improve affordability to enhance palliative care and pain management for those in need.
Global Hotspots of Synthetic Drug Trafficking
The report identifies several regions where the trafficking of synthetic drugs is on the rise:
- Europe: The heroin supply is expected to decline due to Afghanistan’s 2022 opium ban, potentially pushing more users toward synthetic alternatives like FYL.
- North America: Despite efforts to curb the crisis, synthetic opioid-related deaths remain at record highs.
- Middle East & Africa: The manufacture and distribution of amphetamine-type stimulants are increasing, yet access to treatment and rehabilitation services remains insufficient.
- Asia-Pacific: Methamphetamine and ketamine trafficking continue to grow, particularly in the Golden Triangle—a long-standing hub for illicit drug production.
A Call for Immediate Action
The INCB is urging world governments to take decisive action, including:
✔ Strengthening international collaboration
✔ Improving data-sharing between nations
✔ Expanding drug prevention and treatment services
Without urgent intervention, the synthetic drug trade will continue to evolve, leading to more overdose deaths, increased addiction rates, and rising public health challenges worldwide.
Source: UN News